No Data
No Data
ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference
Translational data presented during a late-breaker poster session from a head-to-head study of eblasakimab and dupilumab in a human tissue model of COPD indicates that eblasakimab performed better than dupilumab in improving airway function and enhancing bronchodilation at the same concentrations
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher
Asian equities traded in the US as American depositary receipts started the week on a positive note Monday morning, rising 0.45% to 1,974.03 on the S&P Asia 50 ADR Index. From North Asia, the gainers
Tech Stocks Lead Asian Equities Traded in the US as American Depositary Receipts Sharply Higher in Friday Trading
Tech stocks led Asian equities traded in the US as American depositary receipts sharply higher Friday morning, climbing 1.29% to 1,970.40 on the S&P Asia 50 ADR Index. With the gain, the index is pois
Asian Equities Traded in the US as American Depositary Receipts Ease in Thursday Trading
Asian equities traded in the US as American depositary receipts eased Thursday morning, declining 0.04% to 1,950.23 on the S&P Asia 50 ADR Index and paring earlier losses. From North Asia, the gainers
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Asian equities traded in the US as American depositary receipts rose Wednesday morning, climbing 0.71% to 1,938.23 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by e-commerce fas
Asian Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading
Asian equities traded in the US as American depositary receipts were trending modestly higher Tuesday morning, rising 0.36% to 1,911.18 on the S&P Asia 50 ADR Index. From North Asia, the gainers were